以聚合物微球为模板,通过溶胶-凝胶法制备了TiO_2/SiO_2复合中空微球,并分别采用硬脂酸和无机磷酸对内层二氧化钛进行了疏水和亲水改性.扫描电镜(SEM)和氮气吸附-脱附结果表明中空微球具有完整的球形空腔和多孔的壳层孔道结构.傅立叶红外光谱(FTIR)证实了内部疏水及亲水改性层的存在.以布洛芬药物为对象,采用热重分析(TGA)和高效液相色谱(HPLC)考察了不同改性对复合中空微球的载药量及缓释性能的影响.研究结果表明,由于存在疏水作用,硬脂酸改性的中空微球载药量(189.8mg/g)高于未改性中空微球(177.5mg/g),且药物释放速率明显减慢,53h内药物释放率仅为55%;与此相反,无机磷酸亲水改性的中空微球载药量减小(为153.0mg/g),且释放速率提高,10h内释放了将近80%的药物.因此,采用不同的改性基团可以对复合中空微球的药物释放速率进行有效地调控.
The composite TiO_2/SiO_2 hollow spheres (CHSs) were successfully prepared via sol-gel process using carboxyl-functionalized polystyrene spheres as templates. Then the titania layer was selectively modi-fied with stearic acid and phosphate, forming hydrophobic and hydrophilic interior, respectively. Their hol-low and porous structures were confirmed by scanning electron nucroscope (SEM) and N_2 sorption analysis. Fourier transform infrared (FT-IR) spectra indicate that the interaction between the modifiers and the surface of titania is not physical adsorption but chemical combination. Using ibuprofen (IBU) as a model drug, the investigation of drug loading amounts and release rates shows that they can be regulated by suitable modifica-tion. Compare with the unmodified system, the stearic acid modified CHSs exhibit higher drug loading amount and lower release rate due to the hydrophobic effect. The IBU loading amount reaches 189.8mg/g and only about 55% of IBU is released within 53h. However, the phosphate modified CHSs exhibit relatively low drug loading amount (153.0mg/g) and high release rate, probably associated to the hydrophilic shells and charge repulsion. Its release percentage reaches nearly 80% within 10h. Therefore, the produced CHSs have potential application in the sustained drug delivery.
参考文献
| [1] | Im S H,Jeong U,Xia Y.Polymer hollow particles with controllable holes in their srufaces.Nature Materials,2005,4(9):671-675. |
| [2] | Wei W.Ma G H,Hu G,et al.Preparation of hierarchical hollow CaCO_3 particles and the application as anticancer drug carrier.J.Am.Chem.Soc.,2008,130(47):15808-15810. |
| [3] | Son S J,Bai X,Lee S B.Inorganic hollow nanoparticles and nanotubes in nanomedicine (Part Ⅰ):drug/gene delivery applications.Drug Discovery Today,2007,12 (15/16):650-656. |
| [4] | Pei A H.Shen Z W.Yang G S.Pteparation of TiO_2 nanocapsules for loading and release of antimicrobial triclosan molecules.Mater.Lett.,2007.61 (13):2757-2760. |
| [5] | Cao S W,Zhu Y J,Ma M Y,et al.Herarchically nanostructured magnetic hollow spheres of Fe_3O_4 and γ-Fe_2O_3:preparation and potential application in drug delivery.J.Phys.Chem.C,2008,112(6):1851-1856. |
| [6] | Zhu Y F,Shi J L,Li Y S,et al.Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface.Microporous Mesoporous Mater.,2005,85 (1/2):75-81. |
| [7] | Zhu Y F,Shi J L.A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug.Microporous Mesoporous Mater.,2007,103(1/2/3):243-249. |
| [8] | Wu X D,Wang D.Yang S R.Preparation and characterization of stearate-capped titanium dioxide nanoparticles.J.Colloid Interface Sci.,2000,222(1):37-40. |
| [9] | Song Y Y,Bauer S,Schmuki P,et al.Amphiphillic TiO_2 nanotube arrays:an actively controllable drug delivery system.J.Am.Chem.Soc.,2009,131 (12):4230-4232. |
| [10] | Gawalt E S.Avaltroni M J.Koch N,et al.Self-assembly and bonding of alkanephosphonic acids on the native oxide surface of titanium.Langmuir,2001,17 (19):5736-5738. |
| [11] | Mitchell D T,Lee S B.Martin C R.Smart nanotubes for bioseparations and biocatalysis.J.Am.Chem Soc.,2002,124 (40):11864-11865. |
| [12] | Son S J,Reichel J,Lee S B,et al.Magnetic nanotubes for magnetic-field-assisted bioseparation,biointeraction,and drug delivery.J.Am.Chem Soc.,2005.127(20):7316-7317. |
| [13] | Schafer W A,Carr P W.Chromatographic characterization of a phosphate-modified zirconia support for bio-chromatographic applications.J.Chromatogr.,1991,587(22):149-160. |
- 下载量()
- 访问量()
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%